ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 132 filers reported holding ANTARES PHARMA INC in Q1 2019. The put-call ratio across all filers is 1.05 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $8,281 | -16.5% | 2,275 | 0.0% | 0.00% | – |
| Q2 2021 | $9,919 | +6.1% | 2,275 | 0.0% | 0.00% | -100.0% |
| Q1 2021 | $9,350 | +3.0% | 2,275 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $9,077 | +47.8% | 2,275 | 0.0% | 0.00% | – |
| Q3 2020 | $6,143 | -1.8% | 2,275 | 0.0% | 0.00% | – |
| Q2 2020 | $6,256 | +16.5% | 2,275 | 0.0% | 0.00% | -100.0% |
| Q1 2020 | $5,369 | -49.8% | 2,275 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $10,693 | +40.5% | 2,275 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $7,610 | +1.7% | 2,275 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $7,485 | +8.6% | 2,275 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $6,893 | +11.4% | 2,275 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $6,188 | -19.0% | 2,275 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $7,644 | +30.2% | 2,275 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $5,870 | +17.3% | 2,275 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $5,005 | +10.6% | 2,275 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $4,527 | -38.6% | 2,275 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $7,371 | – | 2,275 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sargent Investment Group, LLC | 3,096,355 | $8,422,000 | 5.18% |
| JW Asset Management, LLC | 1,920,524 | $5,224,000 | 3.85% |
| Healthcare Value Capital, LLC | 250,000 | $680,000 | 2.64% |
| ARMISTICE CAPITAL, LLC | 10,300,000 | $28,016,000 | 2.12% |
| Broadfin Capital, LLC | 3,444,147 | $9,368,000 | 1.23% |
| PERKINS CAPITAL MANAGEMENT INC | 409,000 | $1,112,000 | 0.86% |
| MYCIO WEALTH PARTNERS, LLC | 1,896,500 | $5,158,000 | 0.48% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 1,012,600 | $2,754,000 | 0.22% |
| FALCON POINT CAPITAL, LLC | 130,200 | $354,000 | 0.21% |
| Brown Advisory Securities, LLC | 275,000 | $781,000 | 0.15% |